{"id":27405,"date":"2024-06-22T11:52:25","date_gmt":"2024-06-22T06:22:25","guid":{"rendered":"https:\/\/vims.ac.in\/education\/?page_id=27405"},"modified":"2026-04-08T15:15:08","modified_gmt":"2026-04-08T09:45:08","slug":"medical-oncology","status":"publish","type":"page","link":"https:\/\/vims.ac.in\/education\/medical-oncology\/","title":{"rendered":"Medical Oncology"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"27405\" class=\"elementor elementor-27405\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f926cb4 e-con-full e-flex e-con e-parent\" data-id=\"f926cb4\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-bd343a8 elementor-widget__width-inherit elementor-widget elementor-widget-image\" data-id=\"bd343a8\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"160\" src=\"https:\/\/vims.ac.in\/education\/wp-content\/uploads\/2025\/04\/Medical-Oncology-1024x160.jpg\" class=\"attachment-large size-large wp-image-40314\" alt=\"\" srcset=\"https:\/\/vims.ac.in\/education\/wp-content\/uploads\/2025\/04\/Medical-Oncology-1024x160.jpg 1024w, https:\/\/vims.ac.in\/education\/wp-content\/uploads\/2025\/04\/Medical-Oncology-300x47.jpg 300w, https:\/\/vims.ac.in\/education\/wp-content\/uploads\/2025\/04\/Medical-Oncology-768x120.jpg 768w, https:\/\/vims.ac.in\/education\/wp-content\/uploads\/2025\/04\/Medical-Oncology-535x84.jpg 535w, https:\/\/vims.ac.in\/education\/wp-content\/uploads\/2025\/04\/Medical-Oncology-1536x240.jpg 1536w, https:\/\/vims.ac.in\/education\/wp-content\/uploads\/2025\/04\/Medical-Oncology.jpg 1920w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-7fc1701 e-con-full e-flex e-con e-parent\" data-id=\"7fc1701\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-a8bd46e elementor-widget elementor-widget-hfe-breadcrumbs-widget\" data-id=\"a8bd46e\" data-element_type=\"widget\" data-widget_type=\"hfe-breadcrumbs-widget.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<nav aria-label=\"Breadcrumb\"><ul class=\"hfe-breadcrumbs hfe-breadcrumbs-show-home\"><li class=\"hfe-breadcrumbs-item hfe-breadcrumbs-first\"><span class=\"hfe-breadcrumbs-home-icon\"><svg aria-hidden=\"true\" class=\"e-font-icon-svg e-fas-home\" viewBox=\"0 0 576 512\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\"><path d=\"M280.37 148.26L96 300.11V464a16 16 0 0 0 16 16l112.06-.29a16 16 0 0 0 15.92-16V368a16 16 0 0 1 16-16h64a16 16 0 0 1 16 16v95.64a16 16 0 0 0 16 16.05L464 480a16 16 0 0 0 16-16V300L295.67 148.26a12.19 12.19 0 0 0-15.3 0zM571.6 251.47L488 182.56V44.05a12 12 0 0 0-12-12h-56a12 12 0 0 0-12 12v72.61L318.47 43a48 48 0 0 0-61 0L4.34 251.47a12 12 0 0 0-1.6 16.9l25.5 31A12 12 0 0 0 45.15 301l235.22-193.74a12.19 12.19 0 0 1 15.3 0L530.9 301a12 12 0 0 0 16.9-1.6l25.5-31a12 12 0 0 0-1.7-16.93z\"><\/path><\/svg><\/span><a href=\"https:\/\/vims.ac.in\/education\"><span class=\"hfe-breadcrumbs-text\">Home<\/span><\/a><\/li><\/ul><\/nav>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-77f2f236 e-con-full e-flex e-con e-parent\" data-id=\"77f2f236\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-386b7712 e-n-tabs-mobile elementor-widget elementor-widget-n-tabs\" data-id=\"386b7712\" data-element_type=\"widget\" data-settings=\"{&quot;tabs_justify_horizontal&quot;:&quot;start&quot;,&quot;horizontal_scroll&quot;:&quot;disable&quot;}\" data-widget_type=\"nested-tabs.default\">\n\t\t\t\t\t\t\t<div class=\"e-n-tabs\" data-widget-number=\"946566930\" aria-label=\"Tabs. Open items with Enter or Space, close with Escape and navigate using the Arrow keys.\">\n\t\t\t<div class=\"e-n-tabs-heading\" role=\"tablist\">\n\t\t\t\t\t<button id=\"e-n-tab-title-9465669301\" class=\"e-n-tab-title\" aria-selected=\"true\" data-tab-index=\"1\" role=\"tab\" tabindex=\"0\" aria-controls=\"e-n-tab-content-9465669301\" style=\"--n-tabs-title-order: 1;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\tOverview\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t<button id=\"e-n-tab-title-9465669302\" class=\"e-n-tab-title\" aria-selected=\"false\" data-tab-index=\"2\" role=\"tab\" tabindex=\"-1\" aria-controls=\"e-n-tab-content-9465669302\" style=\"--n-tabs-title-order: 2;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\tFaculty\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t<button id=\"e-n-tab-title-9465669303\" class=\"e-n-tab-title\" aria-selected=\"false\" data-tab-index=\"3\" role=\"tab\" tabindex=\"-1\" aria-controls=\"e-n-tab-content-9465669303\" style=\"--n-tabs-title-order: 3;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\tServices\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t<button id=\"e-n-tab-title-9465669304\" class=\"e-n-tab-title\" aria-selected=\"false\" data-tab-index=\"4\" role=\"tab\" tabindex=\"-1\" aria-controls=\"e-n-tab-content-9465669304\" style=\"--n-tabs-title-order: 4;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\tFacilities\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t<button id=\"e-n-tab-title-9465669305\" class=\"e-n-tab-title\" aria-selected=\"false\" data-tab-index=\"5\" role=\"tab\" tabindex=\"-1\" aria-controls=\"e-n-tab-content-9465669305\" style=\"--n-tabs-title-order: 5;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\tPublications\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t<button id=\"e-n-tab-title-9465669306\" class=\"e-n-tab-title\" aria-selected=\"false\" data-tab-index=\"6\" role=\"tab\" tabindex=\"-1\" aria-controls=\"e-n-tab-content-9465669306\" style=\"--n-tabs-title-order: 6;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\tProjects \t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t<button id=\"e-n-tab-title-9465669307\" class=\"e-n-tab-title\" aria-selected=\"false\" data-tab-index=\"7\" role=\"tab\" tabindex=\"-1\" aria-controls=\"e-n-tab-content-9465669307\" style=\"--n-tabs-title-order: 7;\">\n\t\t\t\t\t\t<span class=\"e-n-tab-title-text\">\n\t\t\t\tAwards &amp; Achievements\t\t\t<\/span>\n\t\t<\/button>\n\t\t\t\t\t<\/div>\n\t\t\t<div class=\"e-n-tabs-content\">\n\t\t\t\t<div id=\"e-n-tab-content-9465669301\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-9465669301\" data-tab-index=\"1\" style=\"--n-tabs-title-order: 1;\" class=\"e-active elementor-element elementor-element-791d529c e-con-full e-flex e-con e-child\" data-id=\"791d529c\" data-element_type=\"container\">\n\t\t<div class=\"elementor-element elementor-element-5dbfc7ec e-con-full e-flex e-con e-child\" data-id=\"5dbfc7ec\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-22191b7d elementor-widget elementor-widget-text-editor\" data-id=\"22191b7d\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul style=\"box-sizing: border-box; --bdt-inverse: initial; border: 0px #e6e6e6; outline: 0px; vertical-align: baseline; background-image: initial; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; margin: 0px 0px 20px 35px; padding: 0px; list-style-position: initial; list-style-image: initial; color: #6b6b6b; font-family: Poppins, sans-serif;\"><li>The department of Medical Oncology in Vydehi Cancer Centre has a dedicated and compassionate team of super-specialists who practice evidence-based cancer care for the management of solid and haematological malignancies in children and adults.<\/li><li>From its inception in 2007, the Department of Medical Oncology has been involved in patient care services in almost all divisions of Oncology including Breast, Gastrointestinal, Head &amp; Neck, Lung, Bone, Soft tissue sarcomas, Gynaeconcology, Uro-oncology, Leukemia, Lymphoma and Pediatric tumours.<\/li><li>The Department of Medical Oncology is one of the most cost-effective center of South India and provides specialised services in Inpatient and Day care setting and these services include both Allogenic and Autologous Stem cell transplant, HIPEC(Hyper thermic Intraperitoneal chemotherapy), Immunotherapy, Targeted treatment , Hormonal treatment , \u00a0Intravesical Chemotherapy and Intrathecal Chemotherapy apart from Conventional Chemotherapy.<\/li><li>Complete spectrum of diagnostic services available at our centre that includes PET-CT\/ PSMA-PET, Cytogenetics and Molecular Genetics.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div id=\"e-n-tab-content-9465669302\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-9465669302\" data-tab-index=\"2\" style=\"--n-tabs-title-order: 2;\" class=\" elementor-element elementor-element-18b3a0f4 e-con-full e-flex e-con e-child\" data-id=\"18b3a0f4\" data-element_type=\"container\" data-settings=\"{&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t<div class=\"elementor-element elementor-element-277c006 e-con-full e-flex e-con e-child\" data-id=\"277c006\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-9551d71 elementor-widget elementor-widget-text-editor\" data-id=\"9551d71\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<p>VYDEHI INSTITUTE OF MEDICAL SCIENCES &amp; RESEARCH CENTRE, BANGALORE<\/p><p>DEPARTMENT OF MEDICAL ONCOLOGY<\/p><p>LIST OF FULL TIME TEACHING FACULTIES<\/p><p>Month and Year of submission of details : <strong>05.04.2026(5th April 2026)<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-562657b elementor-widget elementor-widget-text-editor\" data-id=\"562657b\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<div style=\"overflow-x: auto;\">\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\" cellspacing=\"0\" cellpadding=\"8\">\n<thead>\n<tr>\n<th>SL No<\/th>\n<th>Faculty Name<\/th>\n<th>AEBAS Attend ID<\/th>\n<th>Medical Registration No<\/th>\n<th>Professional Qualification(s)<\/th>\n<th>Department<\/th>\n<th>Designation<\/th>\n<th>Nature of Employment<\/th>\n<th>Total Teaching Experience<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n\n<tr><td>1<\/td><td>Dr. Shashidhar V Karpurmatti<\/td><td>47776900<\/td><td>63461<\/td><td>MBBS, MD, DM<\/td><td>Medical Oncology<\/td><td>Professor &#038; HOD<\/td><td>Permanent<\/td><td>18 Years 6 Months<\/td><\/tr>\n\n<tr><td>2<\/td><td>Dr. Manjunath Irappa Nandenavar<\/td><td>27289129<\/td><td>58014<\/td><td>MBBS, MD, DM<\/td><td>Medical Oncology<\/td><td>Professor<\/td><td>Permanent<\/td><td>16 Years 5 Months<\/td><\/tr>\n\n<tr><td>3<\/td><td>Dr. Veerendra Angadi<\/td><td>569226<\/td><td>87541<\/td><td>MBBS, MD, DM<\/td><td>Medical Oncology<\/td><td>Assistant Professor<\/td><td>Permanent<\/td><td>12 Years 6 Months<\/td><\/tr>\n\n<tr><td>4<\/td><td>Dr. Labon Sarkar<\/td><td>4842679<\/td><td>196294<\/td><td>MBBS, MD, DM<\/td><td>Medical Oncology<\/td><td>Assistant Professor<\/td><td>Permanent<\/td><td>7 Years 0 Months<\/td><\/tr>\n\n<tr><td>5<\/td><td>Dr. Yogitha C<\/td><td>17297867<\/td><td>125636<\/td><td>MBBS, MD<\/td><td>Medical Oncology<\/td><td>Senior Resident<\/td><td>Permanent<\/td><td>2 Years 4 Months<\/td><\/tr>\n\n<tr><td>6<\/td><td>Dr. S Vishnu Vardhan Yedla<\/td><td>51308387<\/td><td>56318<\/td><td>MBBS, MD<\/td><td>Medical Oncology<\/td><td>Senior Resident<\/td><td>Permanent<\/td><td>2 Years 3 Months<\/td><\/tr>\n\n<tr><td>7<\/td><td>Dr. Prakash Shashikant Mishra<\/td><td>43147329<\/td><td>69815<\/td><td>MBBS, DNB<\/td><td>Medical Oncology<\/td><td>Senior Resident<\/td><td>Permanent<\/td><td>2 Years 4 Months<\/td><\/tr>\n\n<tr><td>8<\/td><td>Dr. Bhudevana J<\/td><td>66294439<\/td><td>67280<\/td><td>MBBS, MD<\/td><td>Medical Oncology<\/td><td>Senior Resident<\/td><td>Permanent<\/td><td>0 Years 10 Months<\/td><\/tr>\n\n<tr><td>9<\/td><td>Dr. Giddi Mauryakrishna<\/td><td>16197852<\/td><td>121656<\/td><td>MBBS, MD<\/td><td>Medical Oncology<\/td><td>Senior Resident<\/td><td>Permanent<\/td><td>3 Years 10 Months<\/td><\/tr>\n\n<tr><td>10<\/td><td>Dr. Bharti<\/td><td>8499109<\/td><td>16910<\/td><td>MBBS, MD<\/td><td>Medical Oncology<\/td><td>Senior Resident<\/td><td>Permanent<\/td><td>0 Years 9 Months<\/td><\/tr>\n\n<tr><td>11<\/td><td>Dr. S Adithya Surya<\/td><td>93474800<\/td><td>143786<\/td><td>MBBS, MD<\/td><td>Medical Oncology<\/td><td>Senior Resident<\/td><td>Permanent<\/td><td>0 Years 8 Months<\/td><\/tr>\n\n<tr><td>12<\/td><td>Dr. Lavanya K U<\/td><td>10325528<\/td><td>91414<\/td><td>MBBS, MD (Radiation Oncology)<\/td><td>Medical Oncology<\/td><td>Senior Resident<\/td><td>Permanent<\/td><td>0 Years 8 Months<\/td><\/tr>\n\n<tr><td>13<\/td><td>Dr. Tanusree Paul<\/td><td>82166449<\/td><td>171888<\/td><td>MBBS, MD<\/td><td>Medical Oncology<\/td><td>Senior Resident<\/td><td>Permanent<\/td><td>0 Years 7 Months<\/td><\/tr>\n\n<\/tbody>\n<\/table>\n<\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div id=\"e-n-tab-content-9465669303\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-9465669303\" data-tab-index=\"3\" style=\"--n-tabs-title-order: 3;\" class=\" elementor-element elementor-element-7e64bd6d e-con-full e-flex e-con e-child\" data-id=\"7e64bd6d\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-63bfd13d elementor-widget elementor-widget-text-editor\" data-id=\"63bfd13d\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<ul><li style=\"list-style-type: none;\"><ul><li>Day care Chemotherapy services for various solid malignancies like cancers of breast, lung , colon , stomach , prostate , cervix , head and neck etc<\/li><li>Day care Chemotherapy services for various hematological malignancies like Non- Hodgkins Lymphoma, Hodgkins Lymphoma , Multiple myeloma etc<\/li><li>Inpatient facilities for treatment of various hematologic malignancies like blood cancers (Acute Lymphoblastic Leukemia\u2019s , Acute Myeloid Leukemia\u2019s, Chronic Lymphocytic Leukemia\u2019s , Chronic Myeloid leukemia\u2019s )<\/li><li>Inpatient facilities for administration of neo-adjuvant and adjuvant chemotherapies for bone cancers and soft tissue sarcomas<\/li><li>Sophisticated and Dedicated Bone Marrow Transplant ( Stem cell transplant ) unit for performing Allogenic and Autologous transplants<\/li><li>Immunotherapy and Monoclonal antibody treatment for various cancers<\/li><li>HIPEC (Heated Intraperitoneal Chemotherapy) administration for various cancers like ovarian cancers, stomach and colon cancers, pseudomyxoma peritonea.<\/li><li>Intrathecal chemotherapy administration for various hematological cancers<\/li><li>Hormonal treatment for various cancers like breast, prostate etc.<\/li><\/ul><h6><strong><b>\u00a0<\/b><\/strong><strong><b>Supportive services<\/b><\/strong><\/h6><ul><li>Bone marrow aspiration \/Bone marrow biopsies<\/li><li>Intrathecal chemotherapy administration<\/li><li>Lumbar punctures \/ abdominal and thoracic Paracentesis (Ascitic and pleural fluid tapping)<\/li><li>Chemo port access , flushing and dressing<\/li><\/ul><h6><strong><em><b><i>\u00a0<\/i><\/b><\/em><\/strong><strong><b>Specialty Clinics<\/b><\/strong><\/h6><ul><li>Leukemia Clinic- Tuesdays , 11:00 am to 1:00 pm<\/li><li>Breast Clinic \u2013 Wednesdays , 11:00 am to 1:00 pm<\/li><li>Gynaecology-oncology Clinic \u2013 Thursdays , 11:00 am to 1:00 pm<\/li><\/ul><\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div id=\"e-n-tab-content-9465669304\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-9465669304\" data-tab-index=\"4\" style=\"--n-tabs-title-order: 4;\" class=\" elementor-element elementor-element-1607eaeb e-con-full e-flex e-con e-child\" data-id=\"1607eaeb\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3a94121a elementor-widget elementor-widget-text-editor\" data-id=\"3a94121a\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h6>Outpatient Facilities<\/h6><ul><li>Outpatient consultation rooms with waiting zone<\/li><li>Counselling rooms<\/li><li>Minor OT<\/li><li>Day care facility<\/li><li>Medical Social worker Services<\/li><li>Preventive Oncology OPD<\/li><\/ul><h6><strong><b>Inpatient Facilities<\/b><\/strong><strong><em><b><i>\u00a0<\/i><\/b><\/em><\/strong><\/h6><ul><li>Dedicated Bone Marrow Transplant Unit for both Allogenic and Autologous Stem cell Transplants<\/li><li>Medical Oncology wards with dedicated , well trained and compassionate nursing staff with separate male and Female wards<\/li><li>Intensive care unit with well-trained Intensivist<\/li><li>Paediatric intensive Care Unit with trained pediatricians<\/li><li>Interventional Radiology services \u2013<br \/>Image guided biopsies<br \/>b.Central Venous catheters \u2013 PORT , PICC (peripherally inserted central catheter)<br \/>c.Nerve blocks for pain palliation<br \/>d.Transarterial Chemoembolisation<br \/>e.Radio frequency ablation<\/li><li>Diagnostic facilities<br \/>Immunohistochemistry<br \/>\u00a0b.Flow cytometry<br \/>\u00a0 \u00a0c.Cytogenetics<br \/>\u00a0 \u00a0d.Molecular tests like RT PCR<br \/>\u00a0 \u00a0e.NGS (Next Generation Sequencing)<\/li><li>Pain and palliative unit<br \/>Morphine<br \/>\u00a0b.Nerve Blocks<br \/>\u00a0 \u00a0c.High frequency ultrasound \/ microwave heat therapy<\/li><li>24 hours blood and blood components support<\/li><li>24 hours radiology services like ultrasound\/CT \/MRI\/Mammography\/ X ray\/PET CT Scan.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div id=\"e-n-tab-content-9465669305\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-9465669305\" data-tab-index=\"5\" style=\"--n-tabs-title-order: 5;\" class=\" elementor-element elementor-element-78dd4aba e-con-full e-flex e-con e-child\" data-id=\"78dd4aba\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-234858c2 elementor-widget elementor-widget-text-editor\" data-id=\"234858c2\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h6>Publications from the department during the past 05 years: Number of Yearly research publications* by the teaching staff in 2018<\/h6><div style=\"overflow-x: auto;\"><table><tbody><tr><th width=\"4.9000%\"><strong>S no<\/strong><\/th><th width=\"17.6600%\"><strong>Author 1st, 2nd and corresponding author<\/strong><\/th><th width=\"15.8400%\"><strong>Title of paper<\/strong><\/th><th width=\"11.6400%\"><strong>National or International<\/strong><\/th><th width=\"16.4200%\"><strong>Citation of the journal<\/strong><\/th><th width=\"15.8800%\"><strong>Indexing details<\/strong><\/th><th width=\"10.0200%\"><strong>Date of publication<\/strong><\/th><th width=\"7.6600%\"><strong>Pageno, vol,ISSN no<\/strong><\/th><\/tr><tr><td width=\"4.9000%\">1.<\/td><td width=\"17.6600%\">Dr. Shashidhar V \u00a0\u00a0Karpurmath ( First Author )<\/td><td width=\"15.8400%\">Role of preoperative CA-125 levels in predicting the DFS and OS in epithelial ovarian cancer.<\/td><td width=\"11.6400%\">International<\/td><td width=\"16.4200%\">Karpurmath SV, Vivek VS, Nandennavar MI, Angadi V, Sekar A. Role of preoperative CA-125 levels in predicting the DFS and OS in epithelial ovarian cancer. Int J Reprod Contracept Obstetric Gynecology 2018; 7:69-73.<\/td><td width=\"15.8800%\">1.Google Scholar<br \/>2.Pubmed Central<br \/>3.Index Copernicus<br \/>4. Index Medicus<\/td><td width=\"10.0200%\">Jan 2018<\/td><td width=\"7.6600%\">69-73<\/td><\/tr><\/tbody><\/table><h6>Number of Yearly research publications* by the teaching staff in 2019<\/h6><div style=\"overflow-x: auto;\"><table><tbody><tr><th width=\"5.6400%\"><strong>Sl. No<\/strong><\/th><th width=\"11.3600%\"><strong>Author 1st, 2nd and corresponding author<\/strong><\/th><th width=\"13.7400%\"><strong>Title of paper<\/strong><\/th><th width=\"11.0800%\"><strong>National or international<\/strong><\/th><th width=\"18.9000%\"><strong>Citation of the journal<\/strong><\/th><th width=\"21.1800%\"><strong>Indexing details<\/strong><\/th><th width=\"10.0200%\"><strong>Date of publication<\/strong><\/th><th width=\"8.1000%\"><strong>Pageno, vol, ISSN no<\/strong><\/th><\/tr><tr><td width=\"5.6400%\">1<\/td><td width=\"11.3600%\">DR Shashidhar V Karpurmath (Second Author)<\/td><td width=\"13.7400%\">\u00a0Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence.<\/td><td width=\"11.0800%\">International<\/td><td width=\"18.9000%\">Seshachalam A, Karpurmath SV, Rathnam K, Raman SG, Janarthinakani M, Prasad K, et al. Does Interim PET Scan After 2 Cycles of ABVD Predict Outcome in Hodgkin Lymphoma? Real-World Evidence. JGO. 2019 Dec;1-13<\/td><td width=\"21.1800%\">1.Index Medicus\/Medline, 2.Dimensions,<br \/>3.Directory Of Open Access Journals,<br \/>4.Web Of Science<br \/>5.Scopus<\/td><td width=\"10.0200%\">December 2019<\/td><td width=\"8.1000%\">1-13<\/td><\/tr><tr><td width=\"5.6400%\">2<\/td><td width=\"11.3600%\">DR Shashidhar V Karpurmath ( Second Author )<\/td><td width=\"13.7400%\">The correlation of doxorubicin related cardiotoxicity with B-type natriuretic peptide levels in South Indian population.<\/td><td width=\"11.0800%\">International<\/td><td width=\"18.9000%\">Jacob DRK, Karpurmath DSV, Nandennavar DM, Angadi DV. The correlation of doxorubicin related cardiotoxicity with B-type natriuretic peptide levels in South Indian population. Int J Med Res Rev. 2019 Dec 31; 7(6):452-60.<\/td><td width=\"21.1800%\">1.Sciencecentral.Com, 2.Index Medicus<\/td><td width=\"10.0200%\">December 2019<\/td><td width=\"8.1000%\">452-460<\/td><\/tr><tr><td width=\"5.6400%\">3<\/td><td width=\"11.3600%\">DR Shashidhar V Karpurmath (second author)<\/td><td width=\"13.7400%\">Comparison of standard short infusion versus prolonged infusion of Doxorubicin in relation to its cardiotoxicity in South Indian population.<\/td><td width=\"11.0800%\">International<\/td><td width=\"18.9000%\">Jacob RK, Karpurmath SV, Nandennavar M, Angadi V. Comparison of standard short infusion versus prolonged infusion of Doxorubicin in relation to its cardiotoxicity in South Indian population. Int J Res Med Sci. 2019 Oct 24;7(11):4298.<\/td><td width=\"21.1800%\">1.Google Scholar, 1.\u00a0ISSN, 3.Index Copernicus<\/td><td width=\"10.0200%\">October 2019<\/td><td width=\"8.1000%\">4298<\/td><\/tr><tr><td width=\"5.6400%\">4<\/td><td width=\"11.3600%\">DR Veerendra Angadi (First Author)<\/td><td width=\"13.7400%\">Packed red cell blood transfusion practices review in medical oncology unit in a tertiary cancer center, South India.<\/td><td width=\"11.0800%\">International<\/td><td width=\"18.9000%\">Angadi V, Nandennavar M, Karpurmath SV, Jacob R, Donekal Y. Packed red cell blood transfusion practices review in medical oncology unit in a tertiary cancer center, South India. Int J Res Med Sci. 2019 Nov 27;7(12):4433.<\/td><td width=\"21.1800%\">1.Google Scholar, 2.ISSN,<br \/>3.Index Copernicus<\/td><td width=\"10.0200%\">November 2019<\/td><td width=\"8.1000%\">4433<\/td><\/tr><tr><td width=\"5.6400%\">5<\/td><td width=\"11.3600%\">DR Manjunath I Nandennavar( first author)<\/td><td width=\"13.7400%\">Double malignancies: a clinicopathological and outcomes retrospective analysis from a tertiary cancer referral centre in South India.<\/td><td width=\"11.0800%\">International<\/td><td width=\"18.9000%\">Nandennavar MI, Angadi V, Karpurmath SV, Jacob R. Double malignancies: a clinicopathological and outcomes retrospective analysis from a tertiary cancer referral centre in South India. Int J Res Med Sci. 2019 Nov 27; 7(12):4449.<\/td><td width=\"21.1800%\">1.Google Scholar,<br \/>2.ISSN,<br \/>3.Index Copernicus<\/td><td width=\"10.0200%\">November 2019<\/td><td width=\"8.1000%\">4449<\/td><\/tr><\/tbody><\/table><h6>Number of Yearly research publications* by the teaching staff in 2020<\/h6><table><tbody><tr><th width=\"5.5400%\"><strong>S no<\/strong><\/th><th width=\"13.6800%\"><strong>Author 1st, 2nd and corresponding author<\/strong><\/th><th width=\"16.1000%\"><strong>Title of paper<\/strong><\/th><th width=\"11.2800%\"><strong>National or International<\/strong><\/th><th width=\"17.6600%\"><strong>Citation of the journal<\/strong><\/th><th width=\"17.7600%\"><strong>Indexing details<\/strong><\/th><th width=\"10.0200%\"><strong>Date of Publication<\/strong><\/th><th width=\"7.9400%\"><strong>Page no. volume, ISSN no<\/strong><\/th><\/tr><tr><td width=\"5.5400%\">01<\/td><td width=\"13.6800%\">Shashidhar V Karpurmath<\/td><td width=\"16.1000%\">Prognostic Significance of Molecular Profile in Non-metastatic Invasive Breast Cancer: A Multicentre Study from India<\/td><td width=\"11.2800%\">National<\/td><td width=\"17.6600%\">Rathnam, K., Niraimathi, K., Shewade, H.D.\u00a0<em><i>et al.<\/i><\/em>\u00a0Prognostic Significance of Molecular Profile in Non-metastatic Invasive Breast Cancer: A Multicentre Study from India.\u00a0Indian J Gynecol Oncology\u00a0<strong><b>18<\/b><\/strong>, 36 (2020).<\/td><td width=\"17.7600%\">Scopus<\/td><td width=\"10.0200%\">Mar \u00a02020<\/td><td width=\"7.9400%\">11<\/td><\/tr><tr><td width=\"5.5400%\">\u00a0\u00a0\u00a0\u00a002<\/td><td width=\"13.6800%\">DR Shashidhar V Karpurmath ( Second Author)<\/td><td width=\"16.1000%\">Retrospective analysis of clinical manifestations and treatment outcomes of patients diagnosed with langerhans cell histiocytosis from a tertiary cancer hospital in South India.<\/td><td width=\"11.2800%\">International<\/td><td width=\"17.6600%\">Jacob RK, Karpurmath SV, Nandennavar M, Angadi V. Retrospective analysis of clinical manifestations and treatment outcomes of patients diagnosed with langerhans cell histiocytosis from a tertiary cancer hospital in South India. Int J Res Med Sci. 2020 May 26; 8(6):2128.<\/td><td width=\"17.7600%\">1.Google Scholar,<br \/>2.Issn,<br \/>3.Index Copernicus<\/td><td width=\"10.0200%\">May 2020<\/td><td width=\"7.9400%\">2128<\/td><\/tr><tr><td width=\"5.5400%\">03<\/td><td width=\"13.6800%\">Shashidhar V Karpurmath<\/td><td width=\"16.1000%\">Comparison of altered fractionation schedule with concurrent chemo-radiation for squmaous cell carcinoma of head and neck<\/td><td width=\"11.2800%\">International<\/td><td width=\"17.6600%\">K. MV, Narayanan GS, Vishwanathan B, Karpurmath SV, Narayanan S. Comparison of altered fractionation schedule with concurrent chemo-radiation for squamous cell carcinoma of head and neck. International Journal of Research in Medical Sciences. 2020 Jul 24;8(8):2834.<\/td><td width=\"17.7600%\">1.Google Scholar, 2.Issn,<br \/>3.Index Copernicus<\/td><td width=\"10.0200%\">Jul 2020<\/td><td width=\"7.9400%\">1-5<\/td><\/tr><tr><td width=\"5.5400%\">04<\/td><td width=\"13.6800%\">Dr. Shashidhar V \u00a0\u00a0Karpurmath ( First Author )<\/td><td width=\"16.1000%\">Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value\u2014A Multicenter Study From South India.<\/td><td width=\"11.2800%\">International<\/td><td width=\"17.6600%\">Karpurmath SV, Seshachalam A, Selvaraj K, Rajamani P, kumar S, Reddy N, et al. Halving Time of BCR-ABL1 in Chronic Myeloid Leukemia: Is It Better Than Day-90 Value\u2014A Multicenter Study From South India. Clinical Lymphoma Myeloma and Leukemia. 2020 May; 20(5):e205-e211.<\/td><td width=\"17.7600%\"><p>1.Pub-Med,<\/p><p>2.Indexmedicus\/Medline,<\/p><p>3.Embase<\/p><p>4.Scopus<\/p><p>5.Science Citation<\/p><p>Index Expanded<\/p><\/td><td width=\"10.0200%\">May 2020<\/td><td width=\"7.9400%\">e205-e211<\/td><\/tr><\/tbody><\/table><h6>Number of Yearly research publications* by the teaching staff in 2021<\/h6><table><tbody><tr><th width=\"5.3400%\"><strong>S no<\/strong><\/th><th width=\"13.2200%\"><strong>Author 1st, 2nd and corresponding author<\/strong><\/th><th width=\"13.9200%\"><strong>Title of paper<\/strong><\/th><th width=\"14.1400%\"><strong>National or International<\/strong><\/th><th width=\"19.4600%\"><strong>Citation of the journal<\/strong><\/th><th width=\"15.0000%\"><strong>Indexing details<\/strong><\/th><th width=\"9.8200%\"><strong>Date of Publication<\/strong><\/th><th width=\"9.1200%\"><strong>Page no. volume, ISSN no<\/strong><\/th><\/tr><tr><td width=\"5.3400%\">01<\/td><td width=\"13.2200%\">DR Manjunath I Nandennavar (First Author)<\/td><td width=\"13.9200%\">Are taxane based regimens better than non-taxane fluoropyrimidine based regimens in advanced gastric cancer? Findings from an observational multicentre study<\/td><td width=\"14.1400%\">International<\/td><td width=\"19.4600%\">Nandennavar MI, Rathnam K, Murugesan J, Raman GS, Elangovan V, Chinnakali P, et al. Are taxane based regimens better than non-taxane fluoropyrimidine based regimens in advanced gastric cancer? Findings from an observational multicentre study, South India. Int J Res Med Sci. 2021 Jan 29;9(2):423.<\/td><td width=\"15.0000%\"><p>1.Google SCHOLAR,<\/p><p>2.ISSN,<\/p><p>3.INDEX COPERNICUS<\/p><\/td><td width=\"9.8200%\">January 2021<\/td><td width=\"9.1200%\">423<\/td><\/tr><tr><td width=\"5.3400%\">02.<\/td><td width=\"13.2200%\"><p>DR Shashidhar v Karpurmath<\/p><p>(Second author)<\/p><\/td><td width=\"13.9200%\">Role of Interim PET Scan after 2 Cycles of ABVD in Pediatric Hodgkin Lymphoma: Retrospective Multicenter Study from South India.<\/td><td width=\"14.1400%\">International<\/td><td width=\"19.4600%\">Karpurmath SV, Rathnam K, Seshachalam A, Srinivasan A, Scott J, G. RS, et al. Role of Interim PET Scan after 2 Cycles of ABVD in Pediatric Hodgkin Lymphoma: Retrospective Multicenter Study from South India. Indian J Med Paediatr Oncol. 2021 Oct;42(05):415-25.<\/td><td width=\"15.0000%\"><p>1.INDMED<\/p><p>2.WEB Of SCIENCE<\/p><p>3. SCOPUS<\/p><\/td><td width=\"9.8200%\">October 2021<\/td><td width=\"9.1200%\">415-425<\/td><\/tr><\/tbody><\/table><h6>Number of Yearly research publications* by the teaching staff in 2022<\/h6><table><tbody><tr><th width=\"5.6800%\"><strong>Sl. No<\/strong><\/th><th width=\"13.8200%\"><strong>Author 1st, 2nd and corresponding author<\/strong><\/th><th width=\"14.4600%\"><strong>Title of paper<\/strong><\/th><th width=\"12.0600%\"><strong>National or International<\/strong><\/th><th width=\"19.4400%\"><strong>Citation of the journal<\/strong><\/th><th width=\"16.2000%\"><strong>Indexing details<\/strong><\/th><th width=\"10.2800%\"><strong>Date of Publication<\/strong><\/th><th width=\"8.0400%\"><strong>Page no.volume,ISSN no<\/strong><\/th><\/tr><tr><td width=\"5.6800%\">01<\/td><td width=\"13.8200%\">Shashidhar V Karpurmath<\/td><td width=\"14.4600%\">An initial experience of computed tomography-guided trans superior vena caval biopsy: a novel approach for precarious mediastinal lesions<\/td><td width=\"12.0600%\">International<\/td><td width=\"19.4400%\">Rajasekaran M, Pandey S, Ashwathappa S, Mandakulutur GS, Karpurmath SV, Nandennavar MI. An initial experience of computed tomography-guided trans superior vena caval biopsy: a novel approach for precarious mediastinal lesions. Pol J Radiol. 2022 Apr 25;87:e233-e237.<\/td><td width=\"16.2000%\"><p>Index Copurnicus<\/p><p>Pubmed Central<\/p><p>Scopus<\/p><\/td><td width=\"10.2800%\">Apr 2022<\/td><td width=\"8.0400%\"><p>E233-<\/p><p>E237<\/p><\/td><\/tr><tr><td width=\"5.6800%\">02<\/td><td width=\"13.8200%\"><p>Veerendra Angadi<\/p><p>(first author)<\/p><\/td><td width=\"14.4600%\">Clinicopathological features and prognostic factors in endometrial carcinoma: a retrospective analysis from a tertiary cancer centre<\/td><td width=\"12.0600%\">international<\/td><td width=\"19.4400%\">Angadi V, Praisy E, Tatineni T, Karpurmath SV, Nandennavar MI. Clinicopathological features and prognostic factors in endometrial carcinoma: a retrospective analysis from a tertiary cancer centre. International Journal of Research in Medical Sciences. 2022 Aug 29; 10(9):1925.<\/td><td width=\"16.2000%\"><p>1.Google SCHOLAR,<\/p><p>2.ISSN,<\/p><p>3.INDEX COPERNICUS<\/p><\/td><td width=\"10.2800%\">Sep 2022<\/td><td width=\"8.0400%\"><p>1925-<\/p><p>1929<\/p><\/td><\/tr><tr><td width=\"5.6800%\">03<\/td><td width=\"13.8200%\">Manjunath I Nandennavar (first author)<\/td><td width=\"14.4600%\">A Retrospective Study Of Diffuse Large B Cell Lymphoma (DLBCL) From A Tertiary Cancer Hospital In South India.<\/td><td width=\"12.0600%\">International<\/td><td width=\"19.4400%\">Nandennavar M, Nadella A, Priyanka Gv. A Retrospective Study Of Diffuse Large B Cell Lymphoma (Dlbcl) From A Tertiary Cancer Hospital In South India. International Journal Of Scientific Research. 2022 Sep 1; 73\u20134.<\/td><td width=\"16.2000%\"><p>1.\u00a0Google scholar<\/p><p>2.\u00a0Pubmed central<\/p><p>3.\u00a0Index Medicus<\/p><\/td><td width=\"10.2800%\">Sep 2022<\/td><td width=\"8.0400%\">73-74<\/td><\/tr><tr><td width=\"5.6800%\">04<\/td><td width=\"13.8200%\"><p>Manjunath Nandennavar<\/p><p>(first author)<\/p><\/td><td width=\"14.4600%\">An Experience Of Primary Amyloidosis From An Indian Tertiary Cancer Institute In South India.<\/td><td width=\"12.0600%\">International<\/td><td width=\"19.4400%\">Nandennavar M, Vishnu Priyanka G, Angadi V, V K S. An Experience Of Primary Amyloidosis From An Indian Tertiary Cancer Institute In South India. International Journal Of Scientific Research. 2022 Dec 1; 61\u20133.<\/td><td width=\"16.2000%\"><p>1.\u00a0Google scholar<\/p><p>2.\u00a0Pubmed central<\/p><p>3.\u00a0Index Medicus<\/p><\/td><td width=\"10.2800%\">Dec 2022<\/td><td width=\"8.0400%\">61-63<\/td><\/tr><\/tbody><\/table><h6>Number of Yearly research publications* by the teaching staff in 2023<\/h6><table><tbody><tr><th width=\"30\"><strong>Sl. No<\/strong><\/th><th width=\"117\"><strong>Author 1st, 2nd and corresponding author<\/strong><\/th><th width=\"204\"><strong>Title of paper<\/strong><\/th><th width=\"94\"><strong>National or International<\/strong><\/th><th width=\"243\"><strong>Citation of the journal<\/strong><\/th><th width=\"194\"><strong>Indexing details<\/strong><\/th><th width=\"77\"><strong>Date of Publication<\/strong><\/th><th width=\"55\"><strong>Page no.volume, ISSN no<\/strong><\/th><\/tr><tr><td width=\"30\">01<\/td><td width=\"117\"><p>Shashidhar V Karpurmath<\/p><p>(first author)<\/p><\/td><td width=\"204\">Tandem High dose chemotherapy with autologous bone marrow transplantation in germ cell tumour \u2013 Experience from a Tertiary care centre from South India<\/td><td width=\"94\">International<\/td><td width=\"243\">V. Karpurmath Shashidhar, Praisy E, I. Nandennavar Manjunath, Angadi V, Koshy Jacob R. Tandem High Dose Chemotherapy With Autologous Bone Marrow Transplantation In Germ Cell Tumor\u2014 Experience From A Tertiary Care Center From South India. International Journal Of Scientific Research. 2023 Jan 1; 81\u20133.<\/td><td width=\"194\"><p>1.\u00a0Google Scholar<\/p><p>2.\u00a0Pubmed Central<\/p><p>3.\u00a0Index Medicus<\/p><\/td><td width=\"77\">Jan 2023<\/td><td width=\"55\">81-83<\/td><\/tr><tr><td width=\"30\">02<\/td><td width=\"117\"><p>Nitesh Anand,<\/p><p>A Veerendra, Manjunath N, Shashidhar V K<\/p><\/td><td width=\"204\">A case series of hodgkins lymphoma with rare progression in the brain<\/td><td width=\"94\">International<\/td><td width=\"243\">Nitesh Anand, A Veerendra, Manjunath N, Shashidhar V K. A Case Series Of Hodgkin\u2019s Lymphoma With Rare Progression In The Brain. International Journal Of Scientific Research<\/td><td width=\"194\"><p>1.\u00a0Indian Citation Index<\/p><p>2.\u00a0\u00a0NCBI<\/p><p>3.\u00a0Pubmed Central<\/p><p>4.\u00a0Open J Gate<\/p><p>5.\u00a0DJOF<\/p><p>6.\u00a0ICMJAE<\/p><p>7.\u00a0DRJI<\/p><p>8.\u00a0Index Medicus.<\/p><\/td><td width=\"77\">Sep 2023<\/td><td width=\"55\"><strong>\u00a0<\/strong><\/td><\/tr><tr><td width=\"30\">03<\/td><td width=\"117\">A Veerendra, \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0Nitesh Anand, \u00a0\u00a0\u00a0Sachet Saxena, Manjunath N, Shashidhar V K<\/td><td width=\"204\"><p>Clinical profiles and outcomes of young versus elderly patients with multiple myeloma : a retrospective observational study from a tertiary cancer center in south India<\/p><p><strong>\u00a0<\/strong><\/p><\/td><td width=\"94\">International<\/td><td width=\"243\">A Veerendra, Nitesh Anand, Sachet Saxena, Manjunath N, Shashidhar V K. Clinical profiles and outcomes of young versus elderly patients with multiple myeloma: a retrospective observational study from a tertiary cancer centre in south India Cancer Research, Statistics And Treatment.<\/td><td width=\"194\"><p>1.\u00a0DOAJ<\/p><p>2.\u00a0SCIMAGO Journal Ranking<\/p><p>3.\u00a0SCOPUS<\/p><p>4.\u00a0EBSCO<\/p><\/td><td width=\"77\">25 Sep 2023<\/td><td width=\"55\"><strong>\u00a0<\/strong><\/td><\/tr><tr><td width=\"30\">04<\/td><td width=\"117\"><p>Dr A Praneeth Kumar,<\/p><p>Dr Manjunath, Dr Vishnu Priyanka<\/p><\/td><td width=\"204\">Myeloproliferative hyper eosinophilic syndrome: chronic eosinophilic leukaemia<\/td><td width=\"94\">International<\/td><td width=\"243\">Praneeth Kumar (2023). Myeloproliferative Hypereosinophilic Syndrome \u2013 Chronic Eosinophilic Leukemia. MAR Oncology &amp; Hematology (2023) 6:3.<\/td><td width=\"194\"><p>1.\u00a0Google Scholar<\/p><p>2.\u00a0Pubmed Indexed ARTICLES<\/p><p>3.\u00a0OPEN AIRE<\/p><p>4.\u00a0PUBLONS<\/p><p>5.\u00a0ICMJE<\/p><\/td><td width=\"77\">10\/09\/23<\/td><td width=\"55\">\u00a0<\/td><\/tr><tr><td width=\"30\">05<\/td><td width=\"117\">Dr Vishnu Vardhan Juture, Dr Gorla Vishnu Priyanka, Dr Sashidhar VK<\/td><td width=\"204\">A Rare presentation of Wilms Tumor in 2 Yr old child<\/td><td width=\"94\">International<\/td><td width=\"243\">DR VISHNU VARDHAN JUTURE, DR GORLA VISHNU PRIYANKA, DR SASHIDHAR VK. 2023. A Rare presentation of Wilms Tumor in 2 Yr old child. MAR Oncology &amp; Haematology (2023)<\/td><td width=\"194\"><p>1.\u00a0GOOGLE SCHOLAR<\/p><p>2.\u00a0Pubmed Indexed Articles<\/p><p>3.\u00a0OPEN AIRE<\/p><p>4.\u00a0PUBLONS<\/p><p>5.\u00a0ICMJE<\/p><\/td><td width=\"77\">1\/10\/2023<\/td><\/tr><\/tbody><\/table><\/div><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div id=\"e-n-tab-content-9465669306\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-9465669306\" data-tab-index=\"6\" style=\"--n-tabs-title-order: 6;\" class=\" elementor-element elementor-element-62675991 e-con-full e-flex e-con e-child\" data-id=\"62675991\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4df574d4 elementor-widget elementor-widget-text-editor\" data-id=\"4df574d4\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h6>Ongoing clinical trials<\/h6><ol><li>Phase-I studies- A Phase 1, Open Label, Dose Escalation, Dose Expansion, Multicentre, First in Human (FIH) Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of Oral AUR107 in Patients with Relapsed Advanced Malignancies. Principal investigators-Dr.Shashidhar.V.K, Co-Investigators-Dr.Manjunath.N, Dr.Veerendra Angadi<\/li><li>\u00a0Phase1, Open Label First in Human Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor GRC 54276 Alone and in Combination with Anti-PD-1 Monoclonal Antibody Pembrolizumab or Anti-PD-L1 Atezolizumab in Subjects with Advanced Solid Tumors and Lymphomas. Principal Investigator- Dr.Manjunath.I.N, CO-Investigators-Dr.Shashidhar.v.Karpurmath, Dr.Veerendra Angadi<\/li><li>NAGA trial: A phase III, multi centre RCT \u2013Neoadjuvant vs adjuvant chemotherapy in gastric Adeno carcinoma. Principal investigators-Dr. Shashidhar. V.K, Co-Investigators-Dr. Manjunath. N, Dr. Veerendra Angadi<\/li><\/ol><h6>Completed clinical trials<\/h6><table><tbody><tr><th width=\"570\"><strong>Indication of trial<\/strong><\/th><th width=\"122\"><strong>Phase of \u00a0Trial<\/strong><\/th><th width=\"160\"><strong>Role In Trial<\/strong><\/th><th width=\"91\"><strong>Year<\/strong><\/th><\/tr><tr><td width=\"570\">A phase IIb\/III,Randomised, Double-blind, Placebo-Controlled, Multicentre, Study of CA-170 in combination with Chemotherapy in patients with Stage IV Non-Squamous Non-Small Cell lung Cancer.<\/td><td width=\"122\">Phase III<\/td><td width=\"160\">Principal Investigator<\/td><td width=\"91\">2023<\/td><\/tr><tr><td width=\"570\">An open label, Multi-Centre, Randomized, Two-Treatment, and Multi dose, parallel, Comparative Bioavailability Study of Bertezomib Injection 3.5mg\/0.2ml and VECADE 3.5mg powder for solution for injection at a dose of .3mg\/m2 in Multiple Myeloma Patients.<\/td><td width=\"122\">Phase-III<\/td><td width=\"160\">Co- Investigator<\/td><td width=\"91\">2021<\/td><\/tr><tr><td width=\"570\">A multi-centre, Double-Blind, randomized parallel Group, Active controlled, Two Part, Phase-III, Global Study to Evaluate the Pharmacokinetics, Effiacy,and Safety of BP 02<strong>\u00a0<\/strong>(Trastuzumab) in Comparison with Herceptin- EU in patients with Her2-positive Early Breast Cancer and Metastatic Breast Cancer.<\/td><td width=\"122\">Phase-III<\/td><td width=\"160\">Co- Investigator<\/td><td width=\"91\">2019-2022<\/td><\/tr><tr><td width=\"570\">Prospective , multi-center, randomized,double-blind,two-arm,parallel group, active control, comparative clinical study to evaluate efficacy and safety of R-TPR_045\/Xgeva for prevention of skeletal related events in patients with bone metastases from solid tumours.<\/td><td width=\"122\">Phase-III<\/td><td width=\"160\">Co- Investigator<\/td><td width=\"91\">2018-2019<\/td><\/tr><tr><td width=\"570\">Metastatic Breast Cancer<\/td><td width=\"122\">Phase-III<\/td><td width=\"160\">Principal Investigator<\/td><td width=\"91\">2017-2018<\/td><\/tr><tr><td width=\"570\">A prospective , Multicenter, randomize, double blind, phase III study to compare the efficacy and safety of Biosimilar Bevacizumab of Enzene Biosciences LTD versus Innovator Bevacizumab both in combination with CAPEOX in Patients with Metastatic Colorectal Cancer<\/td><td width=\"122\">Phase-III<\/td><td width=\"160\">Principal Investigator<\/td><td width=\"91\">2016-2017<\/td><\/tr><tr><td width=\"570\">A randomized open label single dose two treatment three sequence partial replicate cross over multicenter bioequivalence study of Capecitabine 500 mg tablets with Xeloda in adult cancer patients under fed conditions-\u00a0<strong>Completed US FDA inspection for the same.<\/strong><\/td><td width=\"122\">Phase-III<\/td><td width=\"160\">Principal Investigator<\/td><td width=\"91\">2018-2019<\/td><\/tr><\/tbody><\/table><h6>ICMR Project study<\/h6><ul><li>To validate the utility of Chemotherapy Risk Assessment Scale for High Age patients (CRASH score) in predicting chemotherapy toxicity in elderly cancer patients.<br \/>Research proposal accepted by ICMR under STS (Short term Studentship) for the year 2020.<\/li><\/ul>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div id=\"e-n-tab-content-9465669307\" role=\"tabpanel\" aria-labelledby=\"e-n-tab-title-9465669307\" data-tab-index=\"7\" style=\"--n-tabs-title-order: 7;\" class=\" elementor-element elementor-element-76fa260b e-con-full e-flex e-con e-child\" data-id=\"76fa260b\" data-element_type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-217fab7c elementor-widget elementor-widget-text-editor\" data-id=\"217fab7c\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h6>Shashidhar V Karpurmath , Professor &amp; HOD<\/h6><h6>Awards and Laurels<\/h6><ul><li>Shashidhar V Karpurmath won the 1st prize ORAL PRESENTATION in the HAEMATO-ONCOLOGY section in REAL WORLD EVIDENCE NATIONAL CONFERENCE 2019.<\/li><li>Cleared ESMO certification exam in 2019.<\/li><li>Awarded as the BEST PHYSICIAN of 2019 in RESEARCH CATEGORY at Vydehi.<\/li><li>Is currently, the ORGANISING SECRETARY of COLLABORATIVE MEDICAL ONCOLOGY GROUP (CMOG).<\/li><li>Got approval for conducting ICMR project as guide to MBBS student in the year 2020 titled \u201cTo validate the utility of Chemotherapy Risk Assessment Scale for High Age patients (CRASH score) in predicting chemotherapy toxicity in elderly cancer patients\u201d.<\/li><\/ul><h6>International Conferences<\/h6><ol><li>ESMO update for practicing oncologists 2018, Lugano, Switzerland.<\/li><li>Attended the per mentorship programme in Frankfurt Germany at UKGM (GIESSEN university) in SEPTEMBER 2016.<\/li><\/ol><h6>National Conferences<\/h6><ol><li>Attended REAL WORLD EVIDENCE national conference at Chennai in August 2019 as faculty.<\/li><li>Attended and completed \u2018STRUCTURED OPERATIONAL RESEARCH TRAINING INITIATIVE\u2019 course conducted by THE UNION (International Union against Tuberculosis and Lung Disease) in collaboration with WHO.<\/li><li>Was invited as a speaker at APEX PROFESSIONAL UNIVERSITY on the occasion of WORLD CANCER DAY 2021- delivered a talk titled \u2018IS DIAGNOSIS OF CANCER ALWAYS A DEATH SENTENCE\u2019.<\/li><li>Was appointed as subject expert as part of Local Inspection Committee from RGUHS regarding inspections in KIDWAI \u00a0\u00a0\u00a0\u00a0Memorial Institute Of Oncology, March 2021.<\/li><li>Was appointed as subject expert as part of Expert Committee regarding promotion of the faculty in medical Oncology at KIDWAI 2019, M.S.Ramiah 2019, Manipal Academy of Higher Education 2019.<\/li><\/ol><h6>Presentations in the last 5 years<\/h6><ol><li>Invited as a guest speaker in \u2018SPOTLIGHT ON PRECISION ONCOLOGY CONFERENCE \u2018held at Chennai on 25<sup>th<\/sup>may 2024.<\/li><li>Attended module 3 of SORT IT (Structured operational research training initiative) held at Cachar cancer centre, Silchar Assam in May 7-12, 2024 an initiative of ICMR \u2013NIE.<\/li><li>Invited as a speaker in the 2<sup>nd<\/sup>International global cancer consortium conference held at KMC Manipal on Jan 7<sup>th<\/sup><\/li><li>Attended as an invited faculty for the 8<sup>th<\/sup>edition of year in review breast cancer conference at Mumbai 22<sup>nd<\/sup>\u00a0Jan 2023.<\/li><li>Attended the CMOG ( Collaborative Medical oncology Group ) meeting at Bengaluru on 13\/03\/2022<\/li><li>Invited as Guest Speaker in the CME conducted by G V N Cancer Centre and IMA Trichy at Trichy on 05\/06\/2022 and delivered his lecture on the topic \u2013 Oncology-Physician Rapport in Shared care Model<\/li><li>Invited as faculty and participated as a panelist in the \u201cCancer Pain Management \u201cCME held on 15\/10\/2022 at Vydehi Institute of Medical Sciences and Research Centre.<\/li><li>Invited as faculty and participated as guest speaker and gave a talk in a national webinar on \u201cRecent advances in Lung Cancer Management \u201c in the CME \u2013 Recent Advances in Pulmonology on 06\/12\/2022, conducted by the Department of Pulmonology, \u00a0Vydehi Institute Of Medical Sciences and Research Centre .<\/li><li>Halving time of BCR-Abl1 levels \u2013Is it a better Bet than day 90 Bcr-Abl1 in chronic phase Chronic Myeloid leukemia patients .Presented in Real world Evidence \u2013 National conference conducted at Chennai in august 2019.<\/li><li>Presented the Data on GIST in conference conducted by collaborative Medical Oncology Group at Vijayawada in 2018.<\/li><li>Presented \u2013Should different types of Breast Cancer be staged differently in National conference Breast con 2018, held at Kasturba Medical College Manipal.<\/li><li>Presented the Hospital data at NCDIR meeting held at Bengaluru and also took part in the meeting for consensus on POCSS form for Hematological malignancies for Hospital Based cancer Registries in 2018<\/li><li>Presented in Indian Cancer Congress 2017 held in Bengaluru in a Genitor-Urinary session.<\/li><li>Presented in Molecular Tumor Board of CML \u2013 International Conference held in Chennai in 2016.<\/li><li>Presented a poster in ISMPO-ISO conference held in Mumbai in 2015.<\/li><li>Attended the CMOG (Collaborative Medical oncology Group) meeting at Bengaluru on 13\/03\/2022<\/li><li>Attended the \u201cCancer Pain Management \u201cCME held on 15\/10\/2022 at Vydehi Institute of Medical Sciences and Research Centre.<\/li><li>Attended the national webinar on \u201cRecent advances in Lung Cancer Management \u201c in the CME \u2013 Recent Advances in Pulmonology on 06\/12\/2022,conducted by the Department of Pulmonology, Vydehi Institute Of Medical Sciences and Research Centre<\/li><li>Attended REAL WORLD EVIDENCE national conference at Chennai in August 2019 as faculty.<\/li><\/ol><h6>Recognized by University for additional roles &amp; responsibilities<\/h6><ol><li>Appointed as External Member of Board of Studies for Medical Oncology at Kasturba Medical College, Manipal Academy of Higher Education (MAHE) from 2020 to 2024<\/li><li>Appointed as part of Local inspection committee as subject expert for Inspection at Kidwai cancer centre as per the appointment order RGU\/AC2\/AFF\/MED\/LIC\/2020-21 dated 26\/02\/2021<\/li><li>Appointed to monitor the research activities pertaining to 2 Medical Oncology \u00a0Research projects for the year 2018-19 as per the appointment order RGU\/ADV-RES\/BR\/001\/2018-19 dated 15\/09\/2020<\/li><li>Appointed as External examiner for the DM Medical Oncology practical exams at Amrita Vishwa Vidyapeetha, Kochi; Sri Aurobindo Institute of Medical College, Indore; \u00a0Madras Medical College, Chennai; Madurai Medical College, Madurai; Kasturba Medical College, Manipal from 2017 to 2024<\/li><li>Appointed as Internal examiner for the DM Medical Oncology practical exams at Kidwai memorial Institute of Oncology in the year 2017 and 2018<\/li><li>Appointed as Internal examiner for the DM Medical oncology practical Examinations at Vydehi Institute of medical Sciences and Research Centre in the years 2016, 2017, 2019, 2021 and \u00a02023<\/li><li>Has been appointed as part of Committee as Subject expert in Medical Oncology \u00a0for the selection \/ promotion for the faculty of Medical Oncology at Kidwai memorial Institute of oncology, Kasturba Medical College and at MS Ramaiah Medical College from 2019 to 2024<\/li><\/ol><h6>Projects undertaken in the last 5 years<\/h6><ol><li>To validate the utility of Chemotherapy Risk Assessment Scale for High Age patients (CRASH score) in predicting chemotherapy toxicity in elderly cancer patients<\/li><li>As a guide to MBBS student ,Ongoing project , research proposal accepted by ICMR under STS (Short term Studentship) for the year 2020<\/li><li>Multi-Centre study was undertaken and completed as part of SORT IT (Structured Operational Research Training Initiative) by THE UNION (International Union against Tuberculosis and Lung Disease) in collaboration with WHO in 2018-19 \u2013 Halving Time of Bcr-Abl1 compared to conventional Day 90 Bcr-Abl1 in chronic myeloid leukemia patients in chronic phase.<\/li><li>Worked as Co-investigator for Neo-adjuvant chemo-radiation therapy in T4 resectable oral cavity cancer project undertaken in the Department of oncology at Vydehi Institute of Medical Sciences and Research Centre \u00a02017-2019<\/li><li>As a guide to DM Medical oncology Post graduate for the project -Comparison of standard short infusion versus prolonged infusion of Doxorubicin in relation to its cardiotoxicity in South Indian population in 2017-2018<\/li><li>As a coinvestigator to the project -Novel single day premedication regimen for prevention of paclitaxel induced hypersensitivity reaction 2017<\/li><li>Ongoing project as PI \u2013 One of the participating centres for the phase III, multi centre RCT \u2013NAGA (Neoadjuvant vs adjuvant chemotherapy in gastric adeno ca).<\/li><li><b><\/b><strong><b>Manjunath Nandennavar , Professor<\/b><\/strong><\/li><\/ol><h6>International Conferences<\/h6><ul><li>Attended ICC conference in Delhi, 2013 and Bangalore, 2019 as a delegate.<\/li><\/ul><h6>Invited as faculty \/ speaker \u2013 National conferences<\/h6><ol><li>Attended the CMOG ( Collaborative Medical oncology Group ) meeting at Bengaluru on 13\/03\/2022<\/li><li>Attended the \u201cCancer Pain Management \u201cCME held on 15\/10\/2022 at Vydehi Institute of Medical Sciences and Research Centre.<\/li><li>Attended the national webinar on \u201cRecent advances in Lung Cancer Management \u201cin the CME \u2013 Recent Advances in Pulmonology on 06\/12\/2022, conducted by the Department of Pulmonology, Vydehi Institute of Medical Sciences and Research Centre.<\/li><li>Attended REAL WORLD EVIDENCE national conference at Chennai in August 2019 as faculty.<\/li><li>.Presented \u2018Comparison of outcomes of 5FU vs. Taxane based chemotherapy regimens in metastatic stomach cancer: results from a tertiary cancer center in south India\u2019 in Real world Evidence \u2013 National conference conducted at Chennai in august 2019.<\/li><\/ol><h6>Projects undertaken in the last 5 years<\/h6><ol><li>As a guide to MBBS student, Ongoing project, research proposal accepted by ICMR under STS (Short term Studentship) for the year 2023.<\/li><li>Multi-center study was undertaken and completed as part of SORT IT (Structured Operational Research Training Initiative) by THE UNION (International Union against Tuberculosis and Lung Disease) in collaboration with WHO in 2018-19 \u2013Comparison of outcomes of 5FU vs. Taxane based chemotherapy regimens in metastatic stomach cancer: results from a tertiary cancer center in south India.<\/li><li>As a PI in Phase1, Open Label First in Human Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor GRC 54276 Alone and in Combination with Anti-PD-1 Monoclonal Antibody Pembrolizumab or Anti-PD-L1 Atezolizumab in Subjects with Advanced Solid Tumors and Lymphomas.<\/li><li>As a CO PI in Phase-I studies- A Phase 1, Open Label, Dose Escalation, Dose Expansion, Multicenter, First in Human (FIH) Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of Oral AUR107 in Patients with Relapsed Advanced Malignancies<\/li><li>As a CO PI in NAGA trial: A phase III, multi centre RCT \u2013Neoadjuvant vs adjuvant chemotherapy in gastric Adeno carcinoma. Principal investigators<\/li><\/ol><h6>Recognized by University for additional roles &amp; responsibilities<\/h6><ol><li>Appointed as external examiner for the DNB Medical Oncology practical exams at Madurai Meenakshi mission institute in February 2024.<\/li><li>Appointed as Internal examiner for the DM Medical oncology practical Examinations at Vydehi Institute of medical Sciences and Research Centre in the years 2019,2020,2021,2022 and 2023.<\/li><li>Has been appointed as part of Committee as Subject expert in Medical Oncology for the selection \/ promotion for the faculty of Medical Oncology at MS Ramaiah medical college in 2024.<\/li><li><b><\/b><strong><b>Veerendra Angadi , Assistant Professor \u00a0<\/b><\/strong><\/li><\/ol><h6>National Conferences<\/h6><ol><li>Attended ISMPO ISO conference in Nov 2015. Presented POSTER presentation on Progressive Multifocal Leukoencephalopathy-Rare demyelinating disorder in a patient with SLL.<\/li><li>VICON 2014, Vydehi Institute of Medical sciences and Research centre, Bangalore.<\/li><li>Pediatric oncology CME programme at Shankara cancer Hospital, Bangalore.<\/li><li>CME on Gastric and OG Junction cancers: Update.<\/li><\/ol><h6>Clinical Research Experience<\/h6><ol><li>A Phase 1, Open Label, Dose Escalation, Dose Expansion, Multicentre, First in Human (FIH) Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of Oral AUR107 in Patients with Relapsed Advanced Malignancies. Co-Investigator.<\/li><li>A phase IIb\/III, Randomized, Double-blind, Placebo-Controlled, Multicenter, Study of CA-170 in combination with Chemotherapy in patients with Stage IV Non-Squamous Non-Small Cell lung Cancer. Co-Investigator.<\/li><li>A Phase1, Open Label First in Human Study Investigating the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of HPK1 Inhibitor GRC 54276 Alone and in Combination with Anti-PD-1 Monoclonal Antibody Pembrolizumab or Anti-PD-L1 Atezolizumab in Subjects with Advanced Solid Tumors and Lymphomas. Co-Investigator.<\/li><li>An open label, Multi-Centre, Randomised, Two-Treatment, Multi dose, parallel, Comparative Bioavailability Study of Bertezomib Injection 3.5mg\/0.2ml and VECADE 3.5mg powder for solution for injection at a dose of .3mg\/m2 in Multiple Myeloma Patients. Co-Investigator.<\/li><li>A multi-centre, Double-Blind, randomized parallel Group, Active controlled, Two Part, Phase-III, Global Study to Evaluate the Pharmacokinetics, Effiacy,and Safety of BP 02(Trastuzumab) in Comparison with Herceptin- EU in patients with Her2-positive Early Breast Cancer and Metastatic Breast Cancer. Co-Investigator.<\/li><li>Prospective , multi-centre, randomized, double-blind, two-arm, parallel group, active control, comparative clinical study to evaluate efficacy and safety of R-TPR_045\/Xgeva for prevention of skeletal related events in patients with bone metastases from solid tumors. Co-Investigator.<\/li><\/ol><h6>RGUHS UNIVERSITY RANK HOLDERS IN DM MEDICAL ONCOLOGY<\/h6><ul><li>Dr. Vishnu Priyanka J- 5<sup>th<\/sup>\u00a0Rank in 2023<\/li><li>Dr. Swaroopa Chundru- 3<sup>rd<\/sup>\u00a0Rank in 2021<\/li><li>Dr. Mehlam Kausar- 4<sup>th<\/sup>\u00a0Rank in 2020<\/li><li>Dr. Sai Vivek V- 2<sup>nd<\/sup>\u00a0Rank in 2019<\/li><\/ul><p><strong>Academic laurels and Achievements of DM Medical Oncology Residents<\/strong><\/p><div><table><tbody><tr><th width=\"37\"><strong><b>Sl. No<\/b><\/strong><\/th><th width=\"67\"><strong><b>SS PG Name<\/b><\/strong><\/th><th width=\"100\"><strong><b>Event \/Conference<\/b><\/strong><\/th><th width=\"135\"><strong><b>Prize \/Presentation<\/b><\/strong><\/th><th width=\"175\"><strong><b>Topic<\/b><\/strong><\/th><th width=\"103\"><strong><b>Date \/ Month &amp;Year<\/b><\/strong><\/th><\/tr><tr><td width=\"37\">I<\/td><td colspan=\"5\" width=\"581\"><strong>Dr. Subha Supriya<\/strong><\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">1<\/td><td width=\"100\">ISMPO \/ ISOCON 2022<\/td><td width=\"135\">Oral presentation<\/td><td width=\"175\">Rare case report on Synovial Sarcoma in Infancy.<\/td><td width=\"103\"><p>October<\/p><p>2022<\/p><\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">2<\/td><td width=\"100\">GI CON<\/td><td width=\"135\">Oral presentation<\/td><td width=\"175\">\u00a0MANEC<\/td><td width=\"103\">May 2023,<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">3<\/td><td width=\"100\">Nuclear Medicine Updates<\/td><td width=\"135\">CME<\/td><td width=\"175\">Nuclear Medicine Updates<\/td><td width=\"103\">DEC 23<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">4<\/td><td width=\"100\">Best of ASCO<\/td><td width=\"135\">Oral presentation<\/td><td width=\"175\">\u00a0<\/td><td width=\"103\">MARCH 2024<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">5<\/td><td width=\"100\">AMOI<\/td><td width=\"135\">2<sup>ND<\/sup>\u00a0PRIZE<\/td><td width=\"175\">AMOI Crossword<\/td><td width=\"103\">MARCH 2024<\/td><\/tr><tr><td width=\"37\">II<\/td><td colspan=\"5\" width=\"581\"><strong>Dr. Shruthi Swamy<\/strong><\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">1<\/td><td width=\"100\">AMOI<\/td><td width=\"135\">1<sup>ST<\/sup>\u00a0PRIZE<\/td><td width=\"175\">Oncology Premier League Quiz<\/td><td width=\"103\">\u00a0June 2022<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">2<\/td><td width=\"100\">AMOI<\/td><td width=\"135\">1<sup>ST<\/sup>\u00a0PRIZE<\/td><td width=\"175\">Debate on Can Triple therapy be made SOC in MCSPC<\/td><td width=\"103\"><p>September<\/p><p>2022<\/p><\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">3<\/td><td width=\"100\">ISMPO \/ ISOCON 2022<\/td><td width=\"135\">Oral presentation<\/td><td width=\"175\">Institutional experience of PCNSL at a tertiary care centre<\/td><td width=\"103\"><p>October<\/p><p>2022<\/p><\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">4<\/td><td width=\"100\">ISMPO \/ ISOCON 2022<\/td><td width=\"135\">Oral presentation<\/td><td width=\"175\">Thiotepa based auto MT in PCNSL<\/td><td width=\"103\">October 2022<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">5<\/td><td width=\"100\">ISMPO \/ ISOCON 2022<\/td><td width=\"135\">Oral presentation<\/td><td width=\"175\">\u00a0Review article on Triplet Therapy in MCSPC<\/td><td width=\"103\">October 2022<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">6<\/td><td width=\"100\">AMOI<\/td><td width=\"135\">1<sup>ST<\/sup>\u00a0PRIZE<\/td><td width=\"175\">Grand Quiz(Oncology Premier League Finals)<\/td><td width=\"103\">November 2022<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">7<\/td><td width=\"100\">AMOI<\/td><td width=\"135\">3<sup>rd<\/sup>\u00a0prize<\/td><td width=\"175\">Oncology Premier League Quiz<\/td><td width=\"103\">August 2023<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">8<\/td><td width=\"100\">Best of ASCO<\/td><td width=\"135\">Oral presentation<\/td><td width=\"175\">CONTACT study phase III trial- Atezolizumab+ Cabozantinib in \u00a0MRCC<\/td><td width=\"103\">MARCH 2024<\/td><\/tr><\/tbody><\/table><\/div><div><table><tbody><tr><td width=\"37\">III<\/td><td colspan=\"5\" width=\"581\"><strong>Dr. Praneetha<\/strong><\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">1<\/td><td width=\"100\">AMOI<\/td><td width=\"135\">1<sup>ST<\/sup>\u00a0PRIZE<\/td><td width=\"175\">AMOI Quiz<\/td><td width=\"103\">AUG 2023<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">2<\/td><td width=\"100\">AMOI<\/td><td width=\"135\">2<sup>ND<\/sup>\u00a0PRIZE<\/td><td width=\"175\">AMOI Crossword<\/td><td width=\"103\">MARCH 2024<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">3<\/td><td width=\"100\">RWE<\/td><td width=\"135\">Oral Presentation<\/td><td width=\"175\">Is FLOT really superior?? A Real world experience from a tertiary cancer centre in India in locally advanced gastric cancer<\/td><td width=\"103\">April,2023<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">4<\/td><td width=\"100\">ISMPO- ISOCON<\/td><td width=\"135\">Oral Presentation<\/td><td width=\"175\">Chronic Myeloid Leukemia in a 3year old child- a rare case report<\/td><td width=\"103\">Oct,2022<\/td><\/tr><tr><td width=\"37\">IV<\/td><td colspan=\"5\" width=\"581\"><strong>Dr. Nitesh Anand<\/strong><\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">1<\/td><td width=\"100\">AMOI<\/td><td width=\"135\">1<sup>ST<\/sup>\u00a0PRIZE<\/td><td width=\"175\">\u00a0Debate on Can Triple therapy be made SOC in mCSPC<\/td><td width=\"103\">\u00a0September 2022<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">2<\/td><td width=\"100\">AMOI<\/td><td width=\"135\">3<sup>RD<\/sup>\u00a0PRIZE<\/td><td width=\"175\">AMOI Quiz<\/td><td width=\"103\">JAN 2024<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">3<\/td><td width=\"100\">AMOI<\/td><td width=\"135\">3<sup>RD<\/sup>\u00a0PRIZE<\/td><td width=\"175\">AMOI Quiz<\/td><td width=\"103\">MARCH 2024<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">4<\/td><td width=\"100\">RWE<\/td><td width=\"135\">POSTER PRESENTATION<\/td><td width=\"175\">MULTIPLE MYELOMA IN YOUNG , INSTITUTIONAL EXPERIENCE<\/td><td width=\"103\">April,2023<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">5<\/td><td width=\"100\">Best of ASCO<\/td><td width=\"135\">Oral presentation<\/td><td width=\"175\">ADJUVANT OSIMERTINIB IN ADENO CA LUNG<\/td><td width=\"103\">MARCH 2024<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">\u00a0<\/td><td width=\"100\">\u00a0<\/td><td width=\"135\">\u00a0<\/td><td width=\"175\">\u00a0<\/td><td width=\"103\">\u00a0<\/td><\/tr><tr><td width=\"37\">V<\/td><td colspan=\"5\" width=\"581\"><strong>Dr. Sachet Saxena<\/strong><\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">1<\/td><td width=\"100\">RWE<\/td><td width=\"135\">ORAL \u00a0PRESENTATION<\/td><td width=\"175\">BMT INSTITUTIONAL EXPERIENCE<\/td><td width=\"103\">April,2023<\/td><\/tr><tr><td width=\"37\">\u00a0<\/td><td width=\"67\">2<\/td><td width=\"100\">Best of ASCO<\/td><td width=\"135\">Oral presentation<\/td><td width=\"175\">PEMBROLIZUMAB IN TKI RESISTANT ADENO CA LUNG<\/td><td width=\"103\">MARCH 2024<\/td><\/tr><\/tbody><\/table><\/div>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Home Overview Faculty Services Facilities Publications Projects Awards &amp; Achievements The department of Medical Oncology in Vydehi Cancer Centre has a dedicated and compassionate team of super-specialists who practice evidence-based [&hellip;]<\/p>\n","protected":false},"author":9,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"class_list":["post-27405","page","type-page","status-publish","hentry"],"aioseo_notices":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Medical Oncology - VIMS-College<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/vims.ac.in\/education\/medical-oncology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Medical Oncology - VIMS-College\" \/>\n<meta property=\"og:description\" content=\"Home Overview Faculty Services Facilities Publications Projects Awards &amp; Achievements The department of Medical Oncology in Vydehi Cancer Centre has a dedicated and compassionate team of super-specialists who practice evidence-based [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/vims.ac.in\/education\/medical-oncology\/\" \/>\n<meta property=\"og:site_name\" content=\"VIMS-College\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-08T09:45:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/vims.ac.in\/education\/wp-content\/uploads\/2025\/04\/Medical-Oncology.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"300\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/vims.ac.in\/education\/medical-oncology\/\",\"url\":\"https:\/\/vims.ac.in\/education\/medical-oncology\/\",\"name\":\"Medical Oncology - VIMS-College\",\"isPartOf\":{\"@id\":\"https:\/\/vims.ac.in\/education\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/vims.ac.in\/education\/medical-oncology\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/vims.ac.in\/education\/medical-oncology\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/vims.ac.in\/education\/wp-content\/uploads\/2025\/04\/Medical-Oncology-1024x160.jpg\",\"datePublished\":\"2024-06-22T06:22:25+00:00\",\"dateModified\":\"2026-04-08T09:45:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/vims.ac.in\/education\/medical-oncology\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/vims.ac.in\/education\/medical-oncology\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/vims.ac.in\/education\/medical-oncology\/#primaryimage\",\"url\":\"https:\/\/vims.ac.in\/education\/wp-content\/uploads\/2025\/04\/Medical-Oncology.jpg\",\"contentUrl\":\"https:\/\/vims.ac.in\/education\/wp-content\/uploads\/2025\/04\/Medical-Oncology.jpg\",\"width\":1920,\"height\":300},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/vims.ac.in\/education\/medical-oncology\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/vims.ac.in\/education\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Medical Oncology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/vims.ac.in\/education\/#website\",\"url\":\"https:\/\/vims.ac.in\/education\/\",\"name\":\"VIMS-College\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/vims.ac.in\/education\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Medical Oncology - VIMS-College","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/vims.ac.in\/education\/medical-oncology\/","og_locale":"en_US","og_type":"article","og_title":"Medical Oncology - VIMS-College","og_description":"Home Overview Faculty Services Facilities Publications Projects Awards &amp; Achievements The department of Medical Oncology in Vydehi Cancer Centre has a dedicated and compassionate team of super-specialists who practice evidence-based [&hellip;]","og_url":"https:\/\/vims.ac.in\/education\/medical-oncology\/","og_site_name":"VIMS-College","article_modified_time":"2026-04-08T09:45:08+00:00","og_image":[{"width":1920,"height":300,"url":"https:\/\/vims.ac.in\/education\/wp-content\/uploads\/2025\/04\/Medical-Oncology.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/vims.ac.in\/education\/medical-oncology\/","url":"https:\/\/vims.ac.in\/education\/medical-oncology\/","name":"Medical Oncology - VIMS-College","isPartOf":{"@id":"https:\/\/vims.ac.in\/education\/#website"},"primaryImageOfPage":{"@id":"https:\/\/vims.ac.in\/education\/medical-oncology\/#primaryimage"},"image":{"@id":"https:\/\/vims.ac.in\/education\/medical-oncology\/#primaryimage"},"thumbnailUrl":"https:\/\/vims.ac.in\/education\/wp-content\/uploads\/2025\/04\/Medical-Oncology-1024x160.jpg","datePublished":"2024-06-22T06:22:25+00:00","dateModified":"2026-04-08T09:45:08+00:00","breadcrumb":{"@id":"https:\/\/vims.ac.in\/education\/medical-oncology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/vims.ac.in\/education\/medical-oncology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/vims.ac.in\/education\/medical-oncology\/#primaryimage","url":"https:\/\/vims.ac.in\/education\/wp-content\/uploads\/2025\/04\/Medical-Oncology.jpg","contentUrl":"https:\/\/vims.ac.in\/education\/wp-content\/uploads\/2025\/04\/Medical-Oncology.jpg","width":1920,"height":300},{"@type":"BreadcrumbList","@id":"https:\/\/vims.ac.in\/education\/medical-oncology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/vims.ac.in\/education\/"},{"@type":"ListItem","position":2,"name":"Medical Oncology"}]},{"@type":"WebSite","@id":"https:\/\/vims.ac.in\/education\/#website","url":"https:\/\/vims.ac.in\/education\/","name":"VIMS-College","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/vims.ac.in\/education\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/vims.ac.in\/education\/wp-json\/wp\/v2\/pages\/27405","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vims.ac.in\/education\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/vims.ac.in\/education\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/vims.ac.in\/education\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/vims.ac.in\/education\/wp-json\/wp\/v2\/comments?post=27405"}],"version-history":[{"count":5,"href":"https:\/\/vims.ac.in\/education\/wp-json\/wp\/v2\/pages\/27405\/revisions"}],"predecessor-version":[{"id":58897,"href":"https:\/\/vims.ac.in\/education\/wp-json\/wp\/v2\/pages\/27405\/revisions\/58897"}],"wp:attachment":[{"href":"https:\/\/vims.ac.in\/education\/wp-json\/wp\/v2\/media?parent=27405"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}